RARPKB

Groups information

Group name

Total

BCR

Continence

Continence

45 (33%)

remark

1 PAD/day

Sexual Function

Sexual function

15 (11%)

remark

Potency with phosphodiesterase type 5 inhibitors

PSA

Complications or other prognosis

Positive surgical margin (PSM)

Other quality of life

Surgical related outcomes

Survival Outcome

Survival Outcome

Other outcomes

Follow Up Time

Follow Up Time

3 months